MAO-A as well as AR-V7 expressions were upregulated in CTCs isolated from patients treated with enzalutamide [16], while MAO-A expression in patient PBMCs was positively correlated with bone metastasis, castration resistance, and the level of serum PSA [52]. This evidence concerns the gene MAOA and bone metastasis.